BYOMass

About:

BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.

Top Investors: Juvenescence

Description:

Total Funding Amount:

$1.5M

Headquarters Location:

Sudbury, Massachusetts, United States

Founded Date:

2017-01-01

Founders:

Margaret Jackson

Number of Employees:

1-10

Last Funding Date:

2019-03-27

IPO Status:

Private

Industries: